EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations

Robert R Edwards, Kristin L Schreiber, Robert H Dworkin, Dennis C Turk, Ralf Baron, Roy Freeman, Troels S Jensen, Alban Latremoliere, John D Markman, Andrew S C Rice, Michael Rowbotham, Roland Staud und 22 weitere

The Journal of Pain · 2023-02 · 24 (2) · 204-225

DOI: 10.1016/j.jpain.2022.08.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Pain, 2023-02. Verfasst von Robert R Edwards und 33 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts. Electronic address: RREdwards@Partners.org. Hauptthemen laut MEDLINE: Chronic Pain. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 226 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCCIH NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Large variability in the individual response to even the most-efficacious pain treatments is observed clinically, which has led to calls for a more personalized, tailored approach to treating patients with pain (ie, "precision pain medicine"). Precision pain medicine, currently an aspirational goal, would consist of empirically based algorithms that determine the optimal treatments, or treatment combinations, for specific patients (ie, targeting the right treatment, in the right dose, to the right patient, at the right time). Answering this question of "what works for whom" will certainly improve the clinical care of patients with pain. It may also support the success of novel drug development in pain, making it easier to identify novel treatments that work for certain patients and more accurately identify the magnitude of the treatment effect for those subgroups. Significant preliminary work has been done in this area, and analgesic trials are beginning to utilize precision pain medicine approaches such as stratified allocation on the basis of prespecified patient phenotypes using assessment methodologies such as quantitative sensory testing. Current major challenges within the field include: 1) identifying optimal measurement approaches to assessing patient characteristics that are most robustly and consistently predictive of inter-patient variation in specific analgesic treatment outcomes, 2) designing clinical trials that can identify treatment-by-phenotype interactions, and 3) selecting the most promising therapeutics to be tested in this way. This review surveys the current state of precision pain medicine, with a focus on drug treatments (which have been most-studied in a precision pain medicine context). It further presents a set of evidence-based recommendations for accelerating the application of precision pain methods in chronic pain research. PERSPECTIVE: Given the considerable variability in treatment outcomes for chronic pain, progress in precision pain treatment is critical for the field. An array of phenotypes and mechanisms contribute to chronic pain; this review summarizes current knowledge regarding which treatments are most effective for patients with specific biopsychosocial characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic PainHumansAnalgesicsPain ManagementPhenotypePain Measurement

Stichwörter der Autor:innen

Painbiomarkerneuropathicpersonalizedphenotypeprecisionquantitative sensory testing

Substanzen

Analgesics

Autor:innen und Institutionen

  • Harvard Medical School, Boston, Massachusetts. Electronic address: RREdwards@Partners.org.
  • Harvard Medical School, Boston, Massachusetts.
  • University of Rochester, Rochester, New York.
  • Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington.
  • Division of Neurological Pain Research and Therapy, Department of Neurology, University Hospital Schleswig-Holstein, Arnold-Heller-Straße 3, House D, 24105 Kiel, Germany.
  • Aarhus University, Aarhus, Denmark.

Förderung

  • NCCIH NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Edwards, R. R., Schreiber, K. L., Dworkin, R. H., Turk, D. C., Baron, R., Freeman, R., Jensen, T. S., Latremoliere, A., Markman, J. D., Rice, A. S. C., Rowbotham, M., Staud, R., Tate, S., Woolf, C. J., Andrews, N. A., Carr, D. B., Colloca, L., Cosma-Roman, D., Cowan, P., …, & Wesselmann, U. (2023). Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations. The Journal of Pain, 24(2), 204-225. https://doi.org/10.1016/j.jpain.2022.08.010

Vancouver

Edwards RR, Schreiber KL, Dworkin RH, Turk DC, Baron R, Freeman R, et al. Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations. The Journal of Pain. 2023;24(2):204-225. doi:10.1016/j.jpain.2022.08.010

BibTeX
@article{Edwards2023,
  author = {Edwards, Robert R and Schreiber, Kristin L and Dworkin, Robert H and Turk, Dennis C and Baron, Ralf and Freeman, Roy and Jensen, Troels S and Latremoliere, Alban and Markman, John D and Rice, Andrew S C and Rowbotham, Michael and Staud, Roland and Tate, Simon and Woolf, Clifford J and Andrews, Nick A and Carr, Daniel B and Colloca, Luana and Cosma-Roman, Doina and Cowan, Penney and Diatchenko, Luda and Farrar, John and Gewandter, Jennifer S and Gilron, Ian and Kerns, Robert D and Marchand, Serge and Niebler, Gwendolyn and Patel, Kushang V and Simon, Lee S and Tockarshewsky, Tina and Vanhove, Geertrui F and Vardeh, Daniel and Walco, Gary A and Wasan, Ajay D and Wesselmann, Ursula},
  title = {Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations},
  journal = {The Journal of Pain},
  year = {2023},
  volume = {24},
  number = {2},
  pages = {204--225},
  doi = {10.1016/j.jpain.2022.08.010}
}
Kostenlos starten →